Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study

    Pharmaceutics, Vol. 15, Núm. 2

2018

  1. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  2. Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems medicine approach

    Pharmacological Reviews, Vol. 70, Núm. 2, pp. 348-383

2016

  1. Adverse Effects of Diabetes Mellitus on the Skeleton of Aging Mice

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 71, Núm. 3, pp. 290-299

2014

  1. Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis

    Oxidative Medicine and Cellular Longevity, Vol. 2014

2011

  1. Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease

    Antioxidants and Redox Signaling, Vol. 15, Núm. 4, pp. 889-901

2009

  1. Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E2 production in osteoarthritic chondrocytes

    Biochemical Pharmacology, Vol. 77, Núm. 12, pp. 1806-1813